Sign In
Buy ICCC
$11.21
+0.150 (+1.36%)
At Close: Jul 31, 2026
ImmuCell to Announce Unaudited Financial Results for Third Quarter of 2020
02:10pm, Thursday, 05'th Nov 2020
Conference Call Scheduled for Friday, November 13, 2020 at 9:00 AM ET Conference Call Scheduled for Friday, November 13, 2020 at 9:00 AM ET
ImmuCell Corporation 2020 Q2 - Results - Earnings Call Presentation
03:41pm, Thursday, 13'th Aug 2020
The following slide deck was published by ImmuCell Corporation in conjunction with their 2020 Q2 earnings call.
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q2 2020 Results - Earnings Call Transcript
01:25pm, Thursday, 13'th Aug 2020
ImmuCell Corporation (NASDAQ:ICCC) Q2 2020 Results Earnings Conference Call August 13, 2020, 9:00 am ET Company Participants Michael Brigham - President, Chief Executive Officer, Director Joe Diaz - I
ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2020
08:05pm, Wednesday, 12'th Aug 2020
PORTLAND, Maine, Aug. 12, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets s
Reviewing ImmuCell (ICCC) & The Competition
04:44am, Sunday, 09'th Aug 2020
ImmuCell (NASDAQ: ICCC) is one of 25 public companies in the “Diagnostic substances” industry, but how does it contrast to its peers? We will compare ImmuCell to related companies based on the str
ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2020
12:00pm, Thursday, 06'th Aug 2020
Conference Call Scheduled for Thursday, August 13, 2020 at 9:00 AM ETPORTLAND, Maine, Aug. 06, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a gr
Contrasting ImmuCell (ICCC) & Its Rivals
04:36am, Monday, 27'th Jul 2020
ImmuCell (NASDAQ: ICCC) is one of 25 publicly-traded companies in the “Diagnostic substances” industry, but how does it weigh in compared to its rivals? We will compare ImmuCell to related compani
Reviewing ImmuCell (ICCC) and Its Competitors
03:56am, Monday, 27'th Jul 2020
ImmuCell (NASDAQ: ICCC) is one of 25 public companies in the “Diagnostic substances” industry, but how does it weigh in compared to its competitors? We will compare ImmuCell to related companies b
Contrasting ImmuCell (ICCC) and Its Peers
02:28am, Wednesday, 22'nd Jul 2020
ImmuCell (NASDAQ: ICCC) is one of 25 public companies in the “Diagnostic substances” industry, but how does it weigh in compared to its competitors? We will compare ImmuCell to related businesses
Perritt Capital Management Manager Commentary Q2 2020
10:50am, Friday, 17'th Jul 2020
Perritt Capital Management is an independent and registered investment advisor located in Chicago's Financial District.
ImmuCell (NASDAQ:ICCC) Receives New Coverage from Analysts at Aegis
05:32am, Tuesday, 14'th Jul 2020
Aegis started coverage on shares of ImmuCell (NASDAQ:ICCC) in a research note released on Monday morning, The Fly reports. The brokerage issued a buy rating and a $14.00 target price on the biotechnol
ImmuCell Announces Preliminary, Unaudited Sales Results for the Second Quarter Ended June 30, 2020
12:00pm, Tuesday, 07'th Jul 2020
ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that im
ImmuCell receives $500,000 loan from Maine Technology Institute
12:23am, Wednesday, 17'th Jun 2020
The Portland-based animal health company will use the funds to help increase its production capacity for one product and complete the development of another.
ImmuCell Receives $500,000 Loan from the Maine Technology
12:00pm, Tuesday, 16'th Jun 2020
ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that im
Edited Transcript of ICCC earnings conference call or presentation 14-May-20 1:00pm GMT
03:48pm, Monday, 18'th May 2020
Q1 2020 ImmuCell Corp Earnings Call
